Cargando…
A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma
BACKGROUND: Carbon ion radiotherapy (CIRT) has been delivered to more than 20,000 patients worldwide. International trials have been recommended in order to emphasize the actual benefits. The ULICE program (Union of Light Ion Centers in Europe) addressed the need for harmonization of CIRT practices....
Autores principales: | Vogin, G., Wambersie, A., Koto, M., Ohno, T., Uhl, M., Fossati, P., Balosso, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359776/ https://www.ncbi.nlm.nih.gov/pubmed/30709366 http://dx.doi.org/10.1186/s13014-019-1224-1 |
Ejemplares similares
-
Long‐term outcomes of skull base chordoma treated with high‐dose carbon‐ion radiotherapy
por: Koto, Masashi, et al.
Publicado: (2020) -
Carbon Ion Radiotherapy: An Evidence-Based Review and Summary Recommendations of Clinical Outcomes for Skull-Base Chordomas and Chondrosarcomas
por: Holtzman, Adam L., et al.
Publicado: (2023) -
Radiomics and Dosiomics for Predicting Local Control after Carbon-Ion Radiotherapy in Skull-Base Chordoma
por: Buizza, Giulia, et al.
Publicado: (2021) -
Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
por: Tubin, Slavisa, et al.
Publicado: (2023) -
Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas
por: Bostel, Tilman, et al.
Publicado: (2018)